Ninevah Therapeutics
Manufacturing · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
10 John Street, London, Greater London, ...Website
www.ninevahtx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Ninevah Therapeutics
Marc is passionate about creating novel biomedical ventures. He is a co-founder and CEO at Rejuversen AG. He is also a co-founder at Ninevah Therapeutics SL and Senolytic Therapeutics Inc. Currently, Marc is a Board member or strategic advisor at Ninevah Therapeutics, Retinset Therapeutics, Cyclomed, Gate2Brain, Cebiotex and Origen Ventures. He is a co-founder and Partner at Chasing Science, an early-stage biomedical venture builder. Marc is also a founder and Advisor at Tech & Business Innovation (TBI), an academic firm focused on knowledge exchange and corporate-academic partnerships. He also supported investments and strategic partnerships at Life Biosciences Inc. in Europe. Marc brings experience as advisor and board member for multiple organizations and as co-founder of several companies. Marc has implemented Entrepreneurs-in-Residence programs at several academic institutions such as IRB Barcelona. From 2019 to 2012, Marc was working for Isis Innovations/University of Oxford as aRead more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ninevah Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Ninevah Therapeutics
Product Launch: Get notified when Ninevah Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Ninevah Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Ninevah Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Ninevah Therapeutics had a recent Job posting/layoffs
Check if Ninevah Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Ninevah Therapeutics recently announced quarterly report
Check out if Ninevah Therapeutics is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Ninevah Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Ninevah Therapeutics
Compare insights from companies similar to Ninevah Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ninevah Therapeutics
<$5M
1-10
Private
-
2019
N/A
Ninevah Therapeutics Tech Stack
A closer look at the technologies used by Ninevah Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Ninevah Therapeutics
Sign Up For FreeTo access detailed company insights
Marc is passionate about creating novel biomedical ventures. He is a co-founder and CEO at Rejuversen AG. He is also a co-founder at Ninevah Therapeutics SL and Senolytic Therapeutics Inc. Currently, Marc is a Board member or strategic advisor at Ninevah Therapeutics, Retinset Therapeutics, Cyclomed, Gate2Brain, Cebiotex and Origen Ventures. He is... Read More
